Periodic Reporting for period 1 - ONCORELIEF (A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment.)
Reporting period: 2020-01-01 to 2021-06-30
In this context, PROMs and PREMs provide a patient-focused, clinically relevant, and reliable perspective on the patient symptom experience. The scientific evidence supporting the use of PROMs and PREMs both on an individual and a population level is ever increasing, and has revealed a variety of benefits for patients and health care professionals. Importantly, using PROMs and PREMs in everyday practice can improve clinicians’ understanding of the effect of disease and treatment on patients’ daily lives, and has the potential to narrow the gap between clinical reality and the patient world.
Thus, a huge unprecedented opportunity is formed to create intelligent healthcare-patient services and tools to manage the health status and wellbeing of cancer patients at all levels. This is true, especially when considering the following key driving factors: (1) Improved cancer survival rate; (2) Proliferation of smartphones; (3) Increased importance of health-related quality of life (HRQOL), (4) Huge volumes of data from clinical, administrative, imaging and omics sources (5) Incoming flood of electronic patient reported outcome and experience measures (ePRO), patient internet activities, sensors and monitoring data and (6) Rapid advances in Artificial Intelligence (AI) and Big Data analytics.
ONCORELIEF is a 3-year action that will leverage, but also skilfully and methodologically overcome technical challenges related to, the above 6 drivers. New approaches will be developed that will allow the utilization of big datasets in order to develop a user-centred AI system, facilitating the integration of quality of life assessment instruments through the use of PROMs and PREMs, with the objective to improve post-treatment health status, wellbeing, and follow-up care of cancer patients in order to meet their needs. This will be achieved through an intuitive smart digital assistant (Guardian Angel), able to utilize big data analytics to provide personalized support in post-treatment activities and tasks, suggest actions regarding the patients’ overall health-status, improved QoL and WB and active health-care and ultimately maintain him/her engaged on a wellness journey that will safeguard his/her health over the foreseeable prolonged post-cancer treatment period. To achieve this, ONCORELIEF builds on the combined knowhow of its interdisciplinary industry-driven consortium that brings together state-of-the-art technological skills, design thinking methodology and occupational psychology/health sciences.
The ONCORELIEF vision is realized through a multi- and trans-disciplinary user-centric approach with concrete technical and scientific objectives (O) and builds upon the following five pillars:
Pillar 1: Analysis of clinical settings, treatment parameters and environment dynamics and driving forces of cancer patient wellbeing
Pillar 2: Exploiting Big Data and AI capabilities for holistic post-treatment insights generation
Pillar 3: Development of innovative technological elements for providing personalized wellbeing
Pillar 4: Piloting in different cancer types and patient-environment settings
Pillar 5: Active engagement of stakeholders resulting to measurable impacts
Until the end of the project, ONCORELIEF will have validated the feasibility of an AI-based solution on supporting post-treatment cancer patients. This will open the road for its uptake by hospitals and cancer clinics around Europe, that will lead to better, more efficient, personalised support for patients.